Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach

Molecular Immunology

Volumn 61, Issue 2, 2014, Pages 110-117

  Grumach, Anete Sevciovic ^a   Kirschfink, Michael ^b  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Complement analysis; Complement deficiencies; Infections; Meningitis; Prevalence; Warning signs

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CD11B ANTIGEN; CD59 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4 BINDING PROTEIN; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9; COMPLEMENT FACTOR H; DECAY ACCELERATING FACTOR; FIBRINOGEN; MANNOSE BINDING LECTIN; MEMBRANE COFACTOR PROTEIN; PROPERDIN; THROMBOMODULIN;

ANGIONEUROTIC EDEMA; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; COMPLEMENT DEFICIENCY; EPIDEMIC MENINGITIS; GENE MUTATION; GLOMERULOPATHY; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNE DEFICIENCY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MENINGOCOCCOSIS; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW;

COMPLEMENT ANALYSIS; COMPLEMENT DEFICIENCIES; INFECTIONS; MENINGITIS; PREVALENCE; WARNING SIGNS;

COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; PREVALENCE;

EID: 84907597606     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.06.030     Document Type: Review

References (95)

1. Aghamohammadi A., Mohammadinejad P., Abolhassani H., Mirminachi B., Movahedi M., Gharagozlou M., Parvaneh N., Zeiaee V., Mirsaeed-Ghazi B., Chavoushzadeh Z., Mahdaviani A., Mansouri M., Yousefzadegan S., Sharifi B., Zandieh F., Hedayat E., Nadjafi A., Sherkat R., Shakerian B., Sadeghi-Shabestari M., Farid Hosseini R., Jabbari-Azad F., Ahanchian H., Behmanesh F., Zandkarimi M., Shirkani A., Cheraghi T., Fayezi A., Mohammadzadeh I., Amin R., Aleyasin S., Moghtaderi M., Ghaffari J., Arshi S., Javahertrash N., Nabavi M., Bemanian M.H., Shafiei A., Kalantari N., Ahmadiafshar A., Khazaei H.A., Atarod L., Rezaei N. Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry. J. Clin. Immunol. 2014, 34:478-490.
2. Agnello V. Lupus diseases associated with hereditary and acquired deficiencies of complement. Springer Semin. Immunopathol. 1986, 9:161-178.
3. Al-Herz W., Bousfiha A., Casanova J.L., Chapel H., Conley M.E., Cunningham-Rundles C., Etzioni A., Fischer A., Franco J.L., Geha R.S., Hammarström L., Nonoyama S., Notarangelo L.D., Ochs H.D., Puck J.M., Roifman C.M., Seger R., Tang M.L. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expertcommittee for primary immunodeficiency. Front Immunol. 2011, 2:1-26.
4. Al-Herz W., Bousfiha A., Casanova J.L., Chatila T., Conley M.E., Cunningham-Rundles C., Etzioni A., Franco J.L., Gaspar H.B., Holland S.M., Klein C., Nonoyama S., Ochs H.D., Oksenhendler E., Picard C., Puck J.M., Sullivan K., Tang M.L. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front. Immunol. 2014, 5:1-33.
5. Al-Tamemi S., Elnour I., Dennison D. Primary immunodeficiency diseases in Oman: five years' experience at sultan qaboos university hospital. World Allergy Organ. J. 2012, 5:52-56.
6. Appel G.B. Membranoprolferative glomerulonephritis-mechanisms and treatment. Contrib. Nephrol. 2013, 181:163-174.
7. Arkwright P.D., Gennery A.R. Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century. Ann. N.Y. Acad. Sci. 2011, 1238:7-14.
8. Atkinson J.P. Complement deficiency: predisposing factor to autoimmune syndromes. Clin. Exp. Rheumatol. 1989, 7:95-101.
9. Bonilla F.A., Bernstein I.L., Khan D.A., Ballas Z.K., Chinen J., Frank M.M., Kobrynski L.J., Levinson A.I., Mazer B., Nelson R.P., Orange J.S., Routes J.M., Shearer W.T., Sorensen R.U. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann. Allergy Asthma Immunol. 2005, 94(5 Suppl 1):S1-S63. American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology.
10. Botto M., Kirschfink M., Macor P., Pickering M.C., Würzner R., Tedesco F. Complement in human diseases: lessons from complement deficiencies. Mol. Immunol. 2009, 46:2774-2783.
11. Bousfiha A., Picard C., Boisson-Dupuis S., Zhang S.Y., Bustamante J., Puel A., Jouanguy E., Ailal F., El-Baghdadi J., Abel L., Casanova J.L. Primary immunodeficiencies of protective immunity to primary infections. Clin. Immunol. 2010, 135:204-209.
12. Boyle J.M., Buckley R.H. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J. Clin. Immunol. 2007, 27:497-502.
13. Calippe B., Guillonneau X., Sennlaub F. Complement factor H and related proteins in age-related macular degeneration. C.R. Biol. 2014, 337:178-184.
14. Carvalho B.T.C., Carneiro-Sampaio M.M., Solé D., Naspitz C., Leiva L.E., Sorensen R.U. Transplacental transmission of serotype-specific pneumococcal antibodies in a Brazilian population. Clin. Diagn. Lab Immunol. 1999, 6:50-54.
15. Casanova J.L., Abel L. Primary Immunodeficiencies: a field in its infancy. Science 2007, 317:617-619.
16. Casanova J.L., Fieschi C., Zhang S.Y., Abel L. Revisiting human primary immunodeficiencies. J. Intern. Med. 2008, 264:115-127.
17. Chapel H. Classification of primary immunodeficiency diseases by the International Union of Immunological Societies (IUIS) Expert Committee on Primary Immunodeficiency 2011. Clin. Exp. Immunol. 2012, 168:58-59.
18. Christmann M., Hansen M., Bergmann C., Schwabe D., Brand J., Schneider W. Eculizumab as first-line therapy for atypical hemolytic uremic syndrome. Pediatrics 2014, 133:e1759-e1763.
19. Cicardi M., Aberer W., Banerji A., Bas M., Bernstein J.A., Bork K., Caballero T., Farkas H., Grumach A., Kaplan A.P., Riedl M.A., Triggiani M., Zanichelli A., Zuraw B. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema. International Working Group. Allergy 2014, 69:602-616. HAWK under the patronage of EAACI (European Academy of Allergy and Clinical Immunology).
20. Cicardi M., Zanichelli A. Acquired angioedema. Allergy Asthma Clin. Immunol. 2010, 6:14-19.
21. Cohn A.C., MacNeil J.R., Clark T.A., Ortega-Sanchez I.R., Briere E.Z., Meissner H.C., Baker C.J., Messonnier N.E. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2013, 6:1-28. Centers for Disease Control and Prevention (CDC).
22. Cohen R., Levy C. Meningococcal vaccines: from polysaccharide to conjugate vaccines. Arch. Pediatr. 2012, 19(Suppl. 2):S61-S64.
23. Costa-Carvalho B.T., Grumach A.S., Franco J.L., Espinosa-Rosales F.J., Leiva L.E., King A., Porras O., Bezrodnik L., Oleastro M., Sorensen R.U., Condino-Neto A. Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice. J. Clin. Immunol. 2014, 34:10-22.
24. Craig T., Aygören-Pürsün E., Bork K., Bowen T., Boysen H., Farkas H., Grumach A., Katelaris C.H., Lockey R., Longhurst H., Lumry W., Magerl M., Martinez-Saguer I., Ritchie B., Nast A., Pawankar R., Zuraw B., Maurer M. WAO Guideline for the Management of Hereditary Angioedema. World Allergy Organ. J. 2012, 5:182-199.
25. Dahl M., Tybjaerg-Hansen A., Schnohr P., Nordestgaard B.G. A population based study of morbidity and mortality in mannose-binding lectin deficiency. J. Exp. Med. 2004, 199:1391-1399.
26. de Cordoba S.R., Tortajada A., Harris C.L., Morgan B.P. Complement dysregulation and disease: from genes and proteins to diagnostics and drugs. Immunobiology 2012, 217:1034-1046.
27. de Vries E. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin. Exp. Immunol. 2012, 167:108-119. European Society for Immunodeficiencies (ESID) members.
28. Degn S.E., Jensenius J.C., Thiel S. Disease-causing mutations in genes of the complement system. Am. J. Hum. Genet. 2011, 88:689-705.
29. Drogari-Apiranhitou M., Fijen C.A.P., Van de Beek D., Hensen E.F., Dankert J., Kuijper E.J. Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients. Clin. Exp. Immunol. 2000, 119:311-316.
30. Elkon K.B., Santer D.M., Wiedeman A. Complement deficiencies and susceptibility to systemic lupus erythematosus revisited. Arthritis Res. Ther. 2012, 14(Suppl 3):A40.
31. Figueroa J.E., Densen P. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 1991, 4:359-395.
32. Fijen C.A., Kuijper E.J., Drogari-Apiranthitou M., Van Leeuwen Y., Daha M.R., Dankert J. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin. Exp. Immunol. 1998, 114:362-369.
33. Fijen C.A., Kuijper E.J., Hannema A.J., Sjöholm A.G., van Putten J.P.M. Complement deficiencies in patients over ten years old with menigococcal disease due to uncommon serogroups. Lancet 1989, 2:585-588.
34. Frakking F.N.J., Brouwer N., Zweers D., Merkus M.P., Kuijpers T.W., Offringa M., Dolman K.M. High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates. Clinical and Experimental Immunology. Clin. Exp. Immunol. 2006, 145:5-12.
35. Fritsche L.G., Fariss R.N., Stambolian D., Abecasis G.R., Curcio C.A., Swaroop A. Age-related macular degeneration: genetics and biology coming together. Annu. Rev. Genet. Hum. Genet. Apr 2014, (Epub ahead of print).
36. Fukumoru Y., Yoshimura K., Ohnoki S., Yamaguchi H., Akagaki Y., Inai S.A. High incidence of C9 deficiency among healthy blood donors in Osaka. Jpn. Int. Immunol. 1989, 1:85-89.
37. Grumach A.S., Leitão M.F., Arruk V.G., Kirschfink M., Condino-Neto A. Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian family. Clin. Exp. Immunol. 2006, 143:297-304.
38. Hanna S., Etzioni A. Leukocyte adhesion deficiencies. Ann. N.Y. Acad. Sci. 2012, 1250:50-55.
39. Hibberd M.L., Sumiya M., Summerfield J.A., Booy R., Levin M. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet 1999, 353:1049-1053. The Meningococcal Research Group.
40. Inai S., Akagaki Y., Moriyama T., Fukumori Y., Yoshimura K., Ohnoki S., Yamaguchi H. Inherited deficiencies of the late acting complement components other than C9 found among healthy blood donors. Int. Arch. Allergy Appl. Immunol. 1989, 90:274-279.
41. Ivanova M., Ruiqing J., Matsushita M., Ogawa T., Kawai S., Ochiai N., Shivarov V., Maruya E., Saji H. MBL2 single nucleotide polymorphism diversity among four ethnic groups as revealed by a bead-based liquid array profiling. Hum. Immunol. 2008, 69:877-884.
42. Johnson C.A., Densen P., Wetsel R.A. Molecular heterogeneity of C2 deficiency. N. Engl. J. Med. 1992, 326:871-874.
43. Joseph C., Gattineni J. Complement disorders and hemolytic uremic syndrome. Curr. Opin. Pediatr. 2013, 25:209-215.
44. Joshi A.Y., Iyer V.N., Hagan J.B., St Sauver J.L., Boyce T.G. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin. Proc. 2009, 84:16-22.
45. Kavai M. Immune complex clearance by complement receptor type 1 in SLE. Autoimmun. Rev. 2008, 8:160-164.
46. Keiser P.B., Broderick M. Meningococcal polysaccharide vaccine failure in a patient with C7 deficiency and a decreased anti-capsular antibody response. Hum. Vaccines Immunother. 2012, 8:582-586.
47. Kilic S.S., Ozel M., Hafizoglu D., Karaca N.E., Aksu G., Kutukculer N. The prevalences and patient characteristics of primary immunodeficiency diseases in Turkey-two centers study. J. Clin. Immunol. 2013, 33:74-83.
48. Klemperer M., Woodworth H.C., Rosen F.S., Austen K.F. Hereditary deficiency of the second component of complement in man. J. Clin. Invest. 1966, 45:880-890.
49. Lahesmaa R., Eerola E., Toivanen A. Does reduced erythrocyte C3b receptor (CR1) activity contribute to the pathogenesis of yersinia triggered reactive arthritis?. Ann. Rheum. Dis. 1992, 51:97-100.
50. Lang D.M., Aberer W., Bernstein J.A., Chng H.H., Grumach A.S., Hide M., Maurer M., Weber R., Zuraw B. International consensus on hereditary and acquired angioedema. Ann. Allergy Asthma Immunol. 2012, 109:395-402.
51. Larsen F., Madsen H.O., Sim R.B., Koch C., Garred P. Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J. Biol. Chem. 2004, 279:21302-21311.
52. Lee P.P.W., Lau Y.L. Primary Immunodeficiencies: "new" disease in an old country. Cell. Mol. Immunol. 2009, 6:397-406.
53. Legendre C., Sberro-Soussan R., Zuber J., Rabant M., Loupy A., Timsit M.O., Anglicheau D. Eculizumab in renal transplantation. Transplant. Rev. (Orlando) 2013, 27:90-92.
54. Lewis L.A., Ram S. Meningococcal disease and the complement system. Virulence 2014, 5:98-126.
55. Litzman J., Freiberger T., Grimbacher B., Gathmann B., Salzer U., Pavlík T., Vlcek J., Postránecká V., Trávnícková Z., Thon V. Mannose-binding lectin gene polymorphic variants predispose to the development of bronchopulmonary complications but have no influence on other clinical and laboratory symptoms or signs of common variable immunodeficiency. Clin. Exp. Immunol. 2008, 153:324-330.
56. Locke B.A., Dasu T., Verbsky J.W. Laboratory diagnosis of primary immunodeficiencies. Clin. Rev. Allergy Immunol. 2014, 46:154-168.
57. Lokki M.L., Colten H.R. Genetic deficiencies of complement. Ann. Med. 1995, 27:451-459.
58. Loirat C., Fremeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J. Rare Dis. 2011, 6:1-30.
59. Maródi L., Casanova J.L. Novel primary immunodeficiencies relevant to internal medicine: novel phenotypes. J. Intern. Med. 2009, 266:502-506.
60. Mayilyan K.R. Complement genetics, deficiencies, and disease associations. Protein Cell 2012, 3:487-496.
61. Modell V., Gee B., Lewis D.B., Orange J.S., Roifman C.M., Routes J.M., Sorensen R.U., Notarangelo L.D., Modell F. Global study of primary immunodeficiency diseases (PI)-diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol. Res. 2011, 51:61-70.
62. Mollnes T.E., Jokiranta T.S., Truedsson L., Nilsson B., Rodriguez de Cordoba S., Kirschfink M. Complement analysis in the 21st century. Mol. Immunol. 2007, 44:3838-3849.
63. Moore H.D. Complementary and opsonic functions in their relation to immunity. A study of the serum of guinea pigs naturally deficient in complement. J. Immunol. 1919, 4:425-441.
64. Naidoo R., Ungerer L., Cooper M., Pienaar S., Eley B.S. Primary immunodeficiencies: a 27-year review at a tertiary paediatric hospital in Cape Town, South Africa. J. Clin. Immunol. 2011, 31:99-105.
65. Nakashima M., Kashii H., Murakami Y., Kato M., Tsurusaki Y., Miyake N., Kubota M., Kinoshita T., Saitsu H., Matsumoto N. Novel compound heterozygous PIGT mutations caused multiple congenital anomalies-hypotonia-seizures syndrome 3. Neurogenetics Jun 2014, (Epub ahead of print).
66. Noris M., Remuzzi G. Atypical hemolytic-uremic syndrome. N. Engl. J. Med. 2009, 361:1676-1687.
67. Ochs H.D., Hitzig W.H. History of primary immunodeficiency diseases. Curr. Opin. Allergy Clin. Immunol. 2012, 12:577-587.
68. Overturf G.D. Indications for the immunological evaluation of patients with meningitis. Clin. Pract. 2003, 36:189-194.
69. O'Sullivan M.D., Cant A.J. The 10 warning signs: a time for a change?. Curr. Opin. Allergy Clin. Immunol. 2012, 12:588-594.
70. Pettigrew H.D., Teuber S.S., Gershwin M.E. Clinical significance of complement deficiencies. Ann. N.Y. Acad. Sci. 2009, 1173:108-123.
71. Pickering M.C., Walport M.J. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology (Oxford) 2000, 39:133-141.
72. Platonov A., Beloborodov V.B., Vershinina I.V. Meningococcal disease in patients with the complement component deficiencies: studies in the U.S.S.R. Medicine 1993, 72:374-392.
73. Rasmussen J.M., Teisner B., Weihe P., Mathiassen B., Petersen T., Isager H. Screening for complement deficiencies in patients surviving from epidemic meningococcal disease. J. Clin. Lab Immunol. 1988, 25:161-165.
74. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
75. Ross S.C., Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 1984, 63:243-273.
76. Scholl H.P., Charbel Issa P., Walier M., Janzer S., Pollok-Kopp B., Börncke F., Fritsche L.G., Chong N.V., Fimmers R., Wienker T., Holz F.G., Weber B.H., Oppermann M. Systemic complement activation in age-related macular degeneration. PLoS One 2008, 3:e2593.
77. Seelen M.A., Roos A., Wieslander J., Mollnes T.E., Sjöholm A.G., Wurzner R., Loos M., Tedesco F., Sim R.B., Garred P., Alexopoulos E., Turner M.W., Daha M.R. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J. Immunol. Methods 2005, 296:187-198.
78. Shulman S.T. The history of pediatric infectious diseases. Pediatr. Res. 2004, 55:163-176.
79. Sjöholm A.G., Kuijper E.I., Tijssen C.C., Jansz A., Bol P., Spanjaard L., Zanen H.C. Dysfunctional properdin in a Dutch family with meningococcal disease. N. Engl. J. Med. 1988, 319:33-37.
80. Skattum L., van Deuren M., van der Poll T., Truedsson L. Complement deficiency states and associated infections. Mol. Immunol. 2011, 48:1643-1655.
81. Skerka C., Chen Q., Fremeaux-Bacchi V., Roumenina L.T. Complement factor H related proteins (CFHRs). Mol. Immunol. 2013, 56:170-180.
82. Søborg C., Madsen H.O., Andersen A., Lillebaek T., Kok-Jensen A., Garred P. Mannose-binding lectin polymorphisms in clinical tuberculosis. J. Infect. Dis. 2003, 188:777-782.
83. Sorensen R., Leiva L., Javier F.C., Sacerdote D.M., Bradford N., Butler B., Giangrosso P.A., Moore C. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J. Allergy Clin. Immunol. 1998, 102:215-221.
84. Sprong T., Roos D., Weemaes C., Neeleman C., Geesing C.L.M., Mollnes T.E., van Deuren M. Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections. Blood 2006, 107:4865-4870.
85. Stengaard-Pedersen K., Thiel S., Gadjeva M., Møller-Kristensen M., Sørensen R., Jensen L.T., Sjøholm A.G., Fugger L., Jensenius J.C. Inherited deficiency of mannan-binding lectin-associated serine protease 2. N. Engl. J. Med. 2003, 349:554-560.
86. Sturfelt G. The complement system in systemic lupus erythematosus. Scand. J. Rheumatol. 2002, 31:129-132.
87. Thiel S., Steffensen R., Christensen I.J., Ip W.K., Lau Y.L., Reason I.J., Eiberg H., Gadjeva M., Ruseva M., Jensenius J.C. Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun. 2007, 8:154-163.
88. Thiel S., Bjerke T., Hansen D., Poulsen L.K., Schiotz P.O., Jensenius J.C. Ontogeny of human mannan-binding protein, a lectin of the innate immune system. Pediatr. Allergy Immunol. 1995, 6:20-23.
89. Thiel J., Kimmig L., Salzer U., Grudzien M., Lebrecht D., Hagena T., Draeger R., Voelxen N., Bergbreiter A., Jennings S., Gutenberger S., Aichem A., Illges H., Hannan J.P., Kienzler A.K., Rizzi M., Eibel H., Peter H.H., Warnatz K., Grimbacher B., Rump J.A., Schlesier M. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J. Allergy Clin. Immunol. 2012, 129:801-810.
90. Tichaczek-Goska D., Witkowska D., Cisowska A., Jankowski S., Hendrich A.B. The bactericidal activity of normal human serum against Enterobacteriaceae rods with lipopolysaccharides possessing O-antigens composed of mannan. Adv. Clin. Exp. Med. 2012, 21:289-299.
91. Tudoran R., Kirschfink M. Modern complement analysis: indications, methods and outlook. J. Lab. Med. 2012, 36:125-134.
92. Vallès X., Roca A., Lozano F., Morais L., Suárez B., Casals F., Mandomando I., Sigaúque B., Nhalungo D., Esquinas C., Quintó L., Alonso P.L., Torres A. Serotype-specific pneumococcal disease may be influenced by mannose-binding lectin deficiency. Eur. Respir. J. 2010, 36:856-863.
93. Wahn V., Späth P. Komplementdefekte. Kinder-und Jugendmedizin 2008, 179-184.
94. Walford H.H., Zuraw B.L. Current update on cellular and molecular mechanisms of hereditary angioedema. Ann. Allergy Asthma Immunol. 2014, 112:413-418.
95. Zuraw B.L., Bork K., Binkley K.E., Banerji A., Christiansen S.C., Castaldo A., Kaplan A., Riedl M., Kirkpatrick C., Magerl M., Drouet C., Cicardi M. Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc. 2012, 33(Suppl 1):S145-S156.